Study: suicidal thoughts fell 70% during Deep TMS treatment for depression
A secondary analysis of 89 patients found faster improvement with BrainsWay's accelerated SWIFT protocol than with standard daily sessions.
A paper in the Journal of Affective Disorders analyzed 89 people with major depression treated with BrainsWay’s Deep TMS in a randomized trial comparing an accelerated “SWIFT” schedule with standard daily sessions. The share of patients reporting suicidal ideation fell from 22.5% to 6.7% after six weeks, a 70% relative reduction. Improvement came faster with SWIFT: a median of 10 days, versus 13 days with standard treatment.
This is a secondary analysis, and Deep TMS isn’t approved to treat suicidality itself. Still, fast-acting non-drug options matter for patients at risk.